TherapeuticsMD, Inc.
Data quality: 67%
TXMD
NASDAQ
Manufacturing
Chemicals
$2.05
▼
$0.03
(-1.59%)
6 months return
—
Momentum
Neutral
ROE
-2.08%
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-2.08%
Above sector avg (-54.47%)
ROIC-10.27%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio2.93
Interest Coverage-548.75
Valuation
P/E Ratio
-41.29
TTM
5.97
NTM
P/B Ratio0.86
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Price History
Financial Trends
Analyst Price Target
No analyst coverage available
Earnings Surprises
EPS
Reported
Estimate
| Q32022 | Q42022 | Q12023 | Q22023 | |
|---|---|---|---|---|
| Reported | -$3.13 | $8.23 | -$0.24 | -$0.24 |
| Estimate | -$2.04 | -$1.11 | $0.06 | -$0.07 |
| Surprise | -53.43% | +841.44% | -500.00% | -242.86% |
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: -2.08% · Net Margin: N/A
Profitability
ROE: -2.08% · Net Margin: N/A| Revenue (TTM) | N/A | Net Income (TTM) | -569,000.0 |
| ROE | -2.08% | ROA | -1.47% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | -10.27% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 2.93
Safety
D/E: N/A · Current: 2.93| Debt / Equity | N/A | Current Ratio | 2.93 |
| Interest Coverage | -548.75 | Asset Turnover | N/A |
| Working Capital | 9.56 M | Tangible Book Value | 23.53 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -41.29 · EV/EBITDA: N/A
Valuation
P/E: -41.29 · EV/EBITDA: N/A| P/E Ratio | -41.29 | Forward P/E | 5.97 |
| P/B Ratio | 0.86 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | 16.75% |
| FCF Yield | N/A | ||
| Market Cap | 23.50 M | Enterprise Value | 23.50 M |
Per Share
EPS: -0.05 · FCF/Share: N/A
Per Share
EPS: -0.05 · FCF/Share: N/A| EPS (Diluted TTM) | -0.05 | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: N/A · CapEx/Rev: N/A
Efficiency
FCF Conv: N/A · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 1.76 M | 1.30 M | 69.96 M | 86.95 M |
| Net Income | -569,000.0 | -2.18 M | -10.28 M | 112.00 M | -172.42 M |
| EPS (Diluted) | -0.05 | -0.19 | -0.98 | 11.96 | — |
| Gross Profit | — | — | 1.30 M | 68.57 M | 68.11 M |
| Operating Income | -4.39 M | -4.76 M | -8.52 M | 1.19 M | -139.77 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | 7.09 M |
| SG&A Expenses | — | 4.74 M | — | — | — |
| D&A | 384,000.0 | 509,000.0 | 922,000.0 | 1.19 M | 4.09 M |
| Interest Expense | 8,000.0 | 9,500.0 | 300,000.0 | 36.07 M | 32.92 M |
| Income Tax | -31,000.0 | -31,000.0 | -43,000.0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 37.66 M | 38.82 M | 43.31 M | 90.46 M | 169.47 M |
| Total Liabilities | 10.78 M | 11.45 M | 14.02 M | 55.32 M | 263.09 M |
| Shareholders' Equity | 26.88 M | 27.37 M | 29.29 M | 35.14 M | -93.62 M |
| Total Debt | — | — | — | 188.27 M | 188.27 M |
| Cash & Equivalents | — | 5.06 M | — | — | — |
| Current Assets | 14.45 M | 12.26 M | 11.80 M | 55.35 M | 119.47 M |
| Current Liabilities | 4.79 M | 5.17 M | 6.85 M | 46.84 M | 252.89 M |
Peer Comparison
vs Manufacturing sector median (1605 peers)
Compared with similar companies in Manufacturing
Peer Comparison
vs Manufacturing sector median (1605 peers) Compared with similar companies in Manufacturing| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -41.3 | -1.5 |
| P/B | 0.9 | 1.6 |
| ROE % | -2.1 | -54.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
{"event":"ticker_viewed","properties":{"ticker":"TXMD","listing_kind":"stock","pathname":"/stocks/txmd","exchange":"NASDAQ","country":"US"}}